Evolution of therapeutic management of patients with ANCA associated vasculitis in France after licensing Rituximab use.
Cécile-Audrey DurelEric Simon ThervetDominique ChauveauAurélie SchmidtBenjamin TerrierPierre M BataillePublished in: BMC rheumatology (2024)
Introduction of rituximab reduced the use of azathioprine without affecting the use of glucocorticoids or cyclophosphamide.